 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - SpringWorks Therapeutics Inc. (SWTX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-17 Purchase | 2019-09-19 7:12 pm | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 50,000 | $18 | $900,000 | 4,593,847 (Indirect) | View |
| 2019-09-17 Purchase | 2019-09-19 7:12 pm | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 275,000 | $18 | $4,950,000 | 7,406,307 (Indirect) | View |
| 2019-09-17 Purchase | 2019-09-19 7:12 pm | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 275,000 | $18 | $4,950,000 | 7,406,307 (Indirect) | View |
| 2019-09-17 Purchase | 2019-09-19 7:05 pm | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 150,000 | $18 | $2,700,000 | 7,281,307 (Indirect) | View |
| 2019-09-17 Purchase | 2019-09-19 4:19 pm | SpringWorks Therapeutics Inc. | SWTX | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 50,000 | $18 | $900,000 | 4,593,847 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-12 Option Award | 2020-03-13 4:01 pm | N/A 2030-03-12 | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 20,000 | $28.76 | 20,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:23 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 325,000 | $33.66 | 325,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:22 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary See Remarks | 75,000 | $33.66 | 75,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:21 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr CFO | 75,000 | $33.66 | 75,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:21 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Renstrup Jens Chief Medical Officer | 50,000 | $33.66 | 50,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:20 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Business Officer | 100,000 | $33.66 | 100,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:30 pm | N/A 2030-02-03 | SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel and Secretary | 106,600 | $33.7 | 106,600 (Direct) | View |
| 2019-12-02 Option Award | 2019-12-03 7:20 pm | N/A 2029-12-02 | SpringWorks Therapeutics Inc. | SWTX | Nofi Michael CAO | 78,300 | $25.45 | 78,300 (Direct) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 978,194 | $0 | 4,593,847 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 3,039,051 | $0 | 4,593,847 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 526,602 | $0 | 4,593,847 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 978,194 | $0 | 4,593,847 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 3,039,051 | $0 | 4,593,847 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 526,602 | $0 | 4,593,847 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 6,078,103 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 1,053,204 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 6,078,103 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 1,053,204 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 6,078,103 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 1,053,204 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 6,078,103 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:12 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 1,053,204 | $0 | 7,406,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:05 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 6,078,103 | $0 | 7,281,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:05 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 1,053,204 | $0 | 7,281,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:05 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 6,078,103 | $0 | 7,281,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 7:05 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 1,053,204 | $0 | 7,281,307 (Indirect) | View |
| 2019-09-17 Conversion | 2019-09-19 4:19 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 978,194 | $0 | 4,593,847 (Direct) | View |
| 2019-09-17 Conversion | 2019-09-19 4:19 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 3,039,051 | $0 | 4,593,847 (Direct) | View |
| 2019-09-17 Conversion | 2019-09-19 4:19 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 526,602 | $0 | 4,593,847 (Direct) | View |
| 2019-09-17 Conversion | 2019-09-19 4:19 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 6,437,500 | $0 | 4,593,847 (Direct) | View |
| 2019-09-17 Conversion | 2019-09-19 4:19 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 20,000,000 | $0 | 4,593,847 (Direct) | View |
| 2019-09-17 Conversion | 2019-09-19 4:19 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 3,465,571 | $0 | 4,593,847 (Direct) | View |
| 2019-09-12 Option Award | 2019-09-16 8:47 pm | N/A 2029-09-12 | SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director | 29,983 | $18 | 29,983 (Direct) | View |
| 2019-03-29 Option Award | 2019-09-16 8:47 pm | N/A 2029-09-12 | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 29,983 | $18 | 526,602 (Direct) | View |
| 2019-03-29 Option Award | 2019-09-16 8:47 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 6,437,500 | $0 | 526,602 (Indirect) | View |
| 2019-03-29 Option Award | 2019-09-16 8:47 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 20,000,000 | $0 | 526,602 (Indirect) | View |
| 2019-03-29 Option Award | 2019-09-16 8:47 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 3,465,571 | $0 | 526,602 (Indirect) | View |
| 2019-09-12 Option Award | 2019-09-16 8:47 pm | N/A 2029-09-12 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 29,983 | $18 | 29,983 (Direct) | View |
| 2019-03-29 Option Award | 2019-09-16 8:47 pm | N/A 2029-09-12 | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 29,983 | $18 | 1,053,204 (Direct) | View |
| 2019-03-29 Option Award | 2019-09-16 8:47 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 40,000,000 | $0 | 1,053,204 (Indirect) | View |
| 2019-03-29 Option Award | 2019-09-16 8:47 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 6,931,142 | $0 | 1,053,204 (Indirect) | View |
| 2019-03-29 Option Award | 2019-09-16 7:52 pm | N/A 2029-09-12 | SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner | 29,983 | $18 | 1,053,204 (Direct) | View |
| 2019-03-29 Option Award | 2019-09-16 7:52 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner | 40,000,000 | $0 | 1,053,204 (Indirect) | View |
| 2019-03-29 Option Award | 2019-09-16 7:52 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner | 6,931,142 | $0 | 1,053,204 (Indirect) | View |